维克中国 Virbac China

关于我们 About us

维克中国 Virbac China

 

Renan Tanguy.jpg

总经理的话:

维克作为中国动物健康产业发展的积极参与者,及在全球动物健康产业中排名第七的企业,我感到非常自豪。

在过去的7年里,维克中国通过一个为客户提供高质量原装产品的销售网络,开展了全面而富有成效的合作,从而成功地实现了扩张。

维克中国的所有成员致力于为宠物主人和农户提供最好的服务,并与兽医院、兽医师、宠物店、线上社区、家禽和猪合作社以及金融投资者合作,在中国共同打造一个更好、更优质的动物医疗保健行业。

我们感谢所有信任我们品牌,并帮助我们进一步成长为一个周到且细心的合作伙伴的你们。

 

唐雷诺

维克中国地区总经理

 

General Manager’s words:

I am proud that Virbac is an active participant of the Animal Health Industry’s development in China and to represent Virbac ranking 7th into the world industry.

Virbac China successfully expanded in the past 7 years thanks to a comprehensive and fruitful collaboration through a network of distributors willing to offer to its customers original products of quality.

All members of Virbac China are devoted to serve on the best way the pet owners and the farmers and co-operate with veterinary hospitals, veterinary practitioners, pet shops, online communities, poultry and swine integrations and financial investors to build a better and qualitative health care sector in China.

We thank all of you who trust our brand and help us grow further as a careful and attentive partner.

 

Renan Tanguy

Virbac China General Manager

 


 

维克中国简介:

  • 维克中国是一个双重法人实体,2003年在北京设立代表处,主要处理法规注册事务,2011年设立维克贸易(上海)有限公司及维克贸易(上海)有限公司北京分公司作为商务子公司。
  • 维克贸易(上海)有限公司与维克贸易(上海)有限公司及法国维克有限公司北京代表处形成南北格局,以覆盖整个中国大陆地区。
  • 双重供应链及资金流动:包括维克中国及法国总部对中国大陆及香港经销商的疫苗直接供应。
  • 由于对伴侣动物产品的专注,维克将伴侣动物产品细分为兽医专用产品及保健产品。兽医专用产品包括临床使用药、处方药及其它需经兽医专业知识所诊断用药,如需经诊断的皮肤病用药。仅供兽医使用药仅出售给兽医医院。保健产品包括与卫生及疾病预防相关的无需兽医师专业指导OTC产品,同时在线上及线下渠道进行销售。
  • 一个长期合作的家禽产品全国经销商及猪用产品的省级经销商网络。

Virbac China as a glance:

  • Virbac China is a double legal entity having a Representative Office settled in 2003 in Beijing to deal with National authorities mainly on Regulatory Affairs and Virbac Trading (Shanghai & Beijing branch) Ltd. Co. settled in 2011 as the commercial affiliate.
  • A double settlement with offices in Beijing for both Representative Office and Branch of Trading Co. and Shanghai as main office of the affiliate in order to cover whole China Mainland territory.
  • A double Supply Chain & Financial flow: by the affiliate and directly from Virbac SA to vaccines distributor in China mainland and to Hong Kong distributor.
  • A strong focus on Companion Animals Products splitting the range into Vet Exclusive Products & Healthcare. Vet Exclusive Products include In Clinic Use, Prescription and products that imply Veterinary practitioner’s expertise for instance in diseases diagnosis such as for dermatological disorders. Vet Exclusive Products are sold to Veterinary Hospitals only. Healthcare range includes OTC products linked to hygiene & prevention of diseases that do not imply a specific consultation then widely sold to online and offline channels.
  • A national historical distributor for poultry products and a network of provincial distributors for swine.

 

维克重要成就:

  • 2016年,维克中国为伴侣动物保健产品系列建立了线上经销网络。
  • 自2017年3月起,维克中国建立了伴侣动物产品的全国线下经销网络,将兽医专用产品仅提供给兽医医院,并将保健产品销售扩大到宠物店。通过这一战略,维克中国加强了对兽医医院的覆盖,并像2016年一样,以保健产品为契机进入线下宠物店。
  • 维克中国在国内创立了新的伴侣动物细分市场,例如2006年创立的皮肤病产品和2012年创立的牙科护理产品。
  • 在过去的两年中,维克中国共推出了5款新的伴侣动物产品,完善了对皮肤科、清洁和营养类产品类目。
  • 维克中国通过赞助活动(展会、连锁诊所和省级兽医协会会议)、技术支持(研讨会、圆桌会议、培训)和经销商(商业协议、培训、营销支持)与所有兽医从业者建立了牢固的关系。维克中国组织维克兽医俱乐部,作为其前身维克皮肤科俱乐部的延续,致力于促进最领先的兽医工作者之间的技术交流与教育。
  • 在皮肤科领域,维克中国是唯一一家提供一系列完整解决方案的公司,通过推出皮乐美(2013年)、乐利鲜(2014年)、耳可舒(2015年)、防御素技术(2016年)、创易合(2017年)以及药浴香波和爱乐滴。
  • 维克中国与国际及国内行业意见领袖合作时间已经有10年。在2015年到2016年,维克中国组织了一个大范围的培训项目,为来自10个主要省份的新皮肤科医生提供专业培训,培训将持续到波尔多举行的第八届世界兽医大会。
  • 维克被宠物主人通过在线问卷选为“用户最喜爱保健品品牌(猫类)”。
  • 通过“耳清爽,眼明亮”的宣传活动,维克中国向美容师和宠物主人普及了眼睛卫生的重要性。
  • 维克中国关注公司团队的成长及发展。当公司超额完成目标,会邀请团队参加由工作会议、团建活动、观光游览相结合的年度奖励之旅。

Virbac China key achievements:

  • In 2016, Virbac China created an online distributors network for the Companion Animals Healthcare range.
  • Since March 2017, Virbac China has set up a national distributors offline networks for all Companion Animals Products keeping Vet Exclusive Products to Veterinary Hospitals only and enlarging Healthcare distribution to pet shops. Through this strategy Virbac China reinforces its coverage to Veterinary Hospitals and enters into offline pet shops with the Healthcare as done with online shops during previous year.
  • Virbac China has created new Companion Animals segments in China such as dermatology in 2006, and dental care in 2012.
  • In past 2 years, Virbac China launched 5 new Companion Animals presentations and products enlarging its offer to dermatology, hygiene and nutritional segments.
  • Virbac China established a strong relationship with all veterinary practitioners through sponsorship of events (congresses, chain clinics and provincial veterinary associations meetings), technical support (workshops, roundtables, trainings) and distributors (commercial agreements, training, marketing support). Virbac China organized the Virbac Veterinary Club as the continuity of previous Virbac Dermato Club to pursue technical exchanges and education between the most advanced veterinary practitioners.
  • In dermatology, Virbac China is the only company that could offer a complete range of solutions through the launch of Cortavance in 2013, Rilexine Compliance in 2014, Easotic in 2015, Defensin technology in 2016, Wound-Gard in 2017 in addition to the dermato shampoos and Allerderm spot on.
  • Virbac China co-operates with international & local OLs for 10 years. In 2015 and 2016, Virbac China organized an extensive training program for new dermatologists from 10 main provinces ending to the 8th World Congress of Veterinary in Bordeaux.
  • Virbac has been elected by pet owners through online survey as one of the favorite brands for cats.
  • Through its campaign “Clean the Ear, Clean the Eye” Virbac China popularized the importance of eye hygiene towards groomers and pet owners.
  • Virbac China cares about team achievement & development. As per company’s results overpassing budget, the team is invited to a yearly incentive trip combining working session, team building activities and sightseeing.

 

微信图片_20181214091250~1.jpg

认识维克
维克集团 Virbac Group

维克集团 Virbac Group

这些创新的解决方案涵盖了主要物种和病理,维克日复一日地为塑造动物健康未来做出贡献。

With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.

创始人 Founder

创始人 Founder

从1968年在尼斯的三室公寓里创建的实验室直到它成为了世界第七大实验室,我们回顾了一个伟大冒险的开端。

From a small biology research center established in 1968 in a three-room apartment in Nice to the world’s 7th largest laboratory, a look back at the beginnings of great human adventure.

价值 Values

价值 Values

培养创业精神,激励创新精神,展示我们的投入,培养以客户为导向的方法,注重以人为本,选择可持续性……

Nurture entrepreneurship, stimulate innovation, demonstrate our engagement, foster a customer-driven approach, pay attention to people and choose sustainability...

历史

1968

1970

1970

1973

1977

1982

1982

1985

1987

1988

1989

1991

1992

1992

1996

1998

1999

1999

2001

2001

2001

2006

2006

2008

2008

2010

2011

2012

2015

2015

2016

2017

2017

2017

1968

PRD.png

建立SARL维克生物研究中心。

Creation of the SARL Virbac biological research center.

1970

1970.png

感谢在比利时、荷兰、卢森堡及德国的分销合作伙伴,维克开始在国际市场营销其产品。

Virbac starts marketing its products internationally, thanks to distribution partnerships in Benelux and Germany.

1970

COLLIER.png

维克为犬类研制了第一款除虫项圈,后来该产品成为公司旗舰产品之一。

Virbac develops the first insecticide collar for dogs, which would later become one of the Group’s flagship products.

1973

batiment-construction.png

维克在尼斯附近的卡罗斯(Carros)建造了其未来总部的第一幢大楼,并迅速成立了生产,储存及装载部门。

Virbac constructs the first building of its future headquarters in Carros, near Nice, quickly adding a production and storage unit and a loading dock.

1977

rilexine.png

维克公司在法国推出了首个头孢菌素的兽医药物(用于犬、猫和牛),从而提供了不使用人用药头孢菌素情况下更好的选择。

Virbac offers the first cephalosporin in veterinary medicine (for dogs, cats and cattle), in France, thus providing an alternative to the cephalosporins derived from human pharmaceuticals.

1982

parvovirus.png

为了应对病毒性肠胃炎导致的大规模犬繁育问题,维克研发了第一种被批准用于犬的基于细小病毒的疫苗,从而成为了极少数有能力研发疫苗的实验室之一。

In response to the viral gastroenteritis epidemic decimating dog breeding, Virbac creates the first parvovirus-based vaccine approved for dogs, thus entering the very exclusive club of innovative vaccine-developing laboratories.

1982

filiale-allemagne.png

在收购了当地经销商VMG后,维克在德国开设了第一家子公司,这标志着维克在欧洲的进一步发展。​

Opening of the first subsidiary in Germany, following acquisition of local distributor VMG, thus marking the beginning of Virbac’s deployment in Europe.

1985

bourse.png

维克——法国第二大动物健康实验室,在巴黎证券交易所的二级市场上市。

Virbac, the number-two French animal health laboratory, starts to trade on the secondary market of the Paris stock exchange.

1987

allerderm.png

通过收购Allerderm Inc., 维克进入了美国,专注于兽医用皮肤科产品这个新的市场,并在几年后成为全球领导者。

With the acquisition of Allerderm Inc., Virbac enters the US market, where it specializes in the new veterinary dermatology market and becomes a global leader a few years later.

1988

leucogen.png

维克用纯化的p45 FeLV-envelope逆转录病毒制成了第一种针对猫白血病的基因工程疫苗,它在猫白血病还没有治愈方法的时候为兽医提供了一种有效的治疗该疾病的方法。​

With the first genetically engineered vaccine against feline leukemia made from a purified p45 FeLV-envelope retrovirus, Virbac provides veterinarians with an effective solution against a disease in cats for which there was no cure at the time.

1989

imperial-dog.png

维克收购了Imperial Dog,一个由皇家的创始人创建的犬、猫的食品生产商,现在成为了维克营养部门。

Virbac acquires Imperial Dog, a dog and cat food manufacturer, founded by the creator of Royal Canin, now Virbac Nutrition.

1991

vaccin-renard.png

在欧洲,维克通过选择性突变的方法为狐狸提供了第一种口服狂犬病疫苗。

In Europe, Virbac offers the first oral anti-rabies vaccine for foxes, obtained by selective mutation.

1992

PRD-JD.png

维克公司创始人,兽医师皮埃尔-理查德-迪克(Pierre-Richard Dick)在一次中美洲海上航行中去世,享年55岁。当时的财务总监帕斯卡尔•博伊斯西(Pascal Boissy)接替他执掌公司。6个月后,公司采用了一个新的组织架构,由执行董事会和监事会组成,创始人的妻子珍妮-迪克(Jeanine Dick)成为董事长。

Veterinarian doctor Pierre-Richard Dick, founder of Virbac, dies suddenly at the age of 55 while on a Central American sea voyage. Pascal Boissy, then financial director, succeeds him to head the company. Six months later, the company adopts a new organizational structure made up of an executive board and a supervisory board, of which Jeanine Dick, wife of the founder, become chairwoman.

1992

asie.png

维克继续其国际扩张,在亚洲建立了第一个子公司(与日本进出口公司丸安合作)。

Virbac continues its international expansion with the creation of its first subsidiary in Asia (a partnership with Maruyasu, a Japanese import-export company).

1996

fusion.png

​许多为了在法国领土上发展而创建的公司合并成一个子公司,维克法国,维克主品牌正式成立。

Numerous companies created to develop the company on French territory merge into a single subsidiary, Virbac France, formalizing the beginning of the Virbac umbrella brand.

1998

jelaime,jelevaccine.png

通过“爱宠物,就让它接种疫苗”的海报宣传活动,维克提高了法国公众对疫苗接种的认识。

Through its “I love my pet, I vaccinate it” poster campaign, Virbac raises the general public’s awareness of vaccination in France.

1999

EM.png

Eric Marée, 48岁,HEC毕业生,美国康奈尔大学工商管理硕士,现任维克执行董事会主席。

Eric Marée, 48 years old, graduate of HEC and holder of an MBA from Cornell University in the United States, becomes chairman of the Virbac executive board.

1999

stlouis.png

由于收购了密苏里州圣路易斯的一家名为Agri-Nutrition的公司,维克新增了一系列牙科护理和清洁用品。

Thanks to the acquisition of Agri-Nutrition, a company based in St. Louis (Missouri), Virbac acquires a range of dental care and hygiene products.

2001

virbagen-omega.png

维克为欧洲的犬、猫提供了第一种干扰素欧米茄。

Virbac offers veterinarians the first interferon omega for dogs and cats in Europe.

2001

fondation2001.png

皮埃尔-理查德·迪克基金会(Pierre-Richard Dick Foundation)Pierre-Richard Dick Foundation成立于1993年,它在创始人去世后更改为维克企业基金会(Virbac Corporate Foundation)。该项目由他的儿子约翰-皮埃尔·迪克(Jean-Pierre Dick)担任主席,旨在提高公众意识,教育并告知(特别对于儿童),在城市中动物健康及人与动物相处的相关问题。​

The Pierre-Richard Dick Foundation, created in 1993 after the founder’s death, becomes the Virbac Corporate Foundation. Chaired by his son, Jean-Pierre Dick, it aims to raise public awareness, educate and inform, especially children, about issues related to the integration and well-being of animals in cities.

2001

JPdick.png

维克与其创始人的儿子约翰-皮埃尔·迪克(Jean-Pierre Dick)一起踏上了他的航海冒险之旅:通过参与史诗般的比赛,这位船长帮助提升了兽医行业,促进了动物健康。

Virbac joins Jean-Pierre Dick, son of the founder and doctor of veterinary medicine, on his sailing adventure: through his involvement in epic races, the skipper helps to enhance the veterinary profession and promote animal health.

2006

MHDick.png

玛丽-海琳·迪克(Marie-Hélène Dick)作为一位专业兽医师和HEC的MBA毕业生被任命为维克监事会主席。

Marie-Hélène Dick, daughter of the founder, veterinary doctor and MBA graduate from HEC, is named chairwoman of Virbac’s supervisory board.

2006

inde.png

通过收购GlaxoSmithKline的动物健康部门Agrivet Farm Care,维克成为在此领域印度排名第一的企业。

Virbac becomes number one in India through the acquisition of Agrivet Farm Care, the animal health branch of GlaxoSmithKline.

2008

prod.png

维克现有7个工业园,分布于五大洲(法国、美国、墨西哥、巴西、澳大利亚、南非和越南)。

With 7 production units, Virbac currently has an industrial park on all five continents (France, United States, Mexico, Brazil, Australia, South Africa and Vietnam).

2008

suprelorin.png

维克为兽医师提供了第一种基于德舍瑞林的植入物,用于诱导雄性犬暂时性不育。

Virbac offers veterinarians the first deslorelin-based implant for the induction of temporary infertility in male dogs.

2010

australie.png

维克与辉瑞签署了一项协议,获得一系列用于食用动物的产品(主要是驱虫药和牛羊疫苗)在澳大利亚的使用权。

Virbac signs an agreement with Pfizer Inc. to acquire the Australian rights to a range of products for food producing animals, primarily parasiticides and vaccines for cattle and sheep.

2011

canileish.png

维克在欧洲推出了第一种针对犬利什曼病的疫苗。

Virbac launches the first vaccine against canine leishmaniasis in Europe.

2012

aqua.png

维克获得了Centrovet的多数股份,Centrovet是智利动物健康市场的领导者,是开发和生产用于冷水养殖农场(鲑鱼和鳟鱼)保护和处理的创新产品的专家。

Virbac acquires a majority share of Centrovet, animal health market leader in Chile, expert in the development and production of innovative products for the protection and treatment of cold water aquaculture farms (salmon and trout).

2015

cochon.png

维克收购了Schweitzer生物技术公司,这是一家台湾公司,他们是细胞培养库开发方面的专家,而细胞培养库是生产用于猪和家禽的病毒疫苗的基础。这一收购正式确立了维克在东南亚建立生物研发的新结构,该地区被公认为全球最大的猪饲养和水产养殖(温水)市场。

Virbac acquires Schweitzer Biotech Company, a Taiwanese company that is an expert in the development of cell culture banks serving as the basis for production of viral vaccines primarily for swine and poultry. This acquisition formalizes the creation of a new biology R&D structure in Southeast Asia, a region recognized for the largest swine and aquaculture (warm water) markets on the planet.

2015

fondation.png

维克企业基金会意识到动物、人类和环境健康之间的相互联系带来的挑战,他们在津巴布韦的Gonarezhou公园发起了一项牛结核病和狂犬病筛查、控制和预防的项目。

The Virbac Corporate Foundation, aware of the challenges related to the interconnection between animal, human, and environmental health, initiates support for a screening, control, and prevention program for bovine tuberculosis and rabies in the Gonarezhou Park (Zimbabwe).

2016

argonavis.png

自2014年在Carros建造了VB8,这是一个致力于生产无菌注射剂的生产大楼,维克投入大量资金以确保其产品品质,并与VB8在墨西哥的另一家公司Argo Navis一起加强生产能力。

After the construction of VB8 in Carros in 2014, a production building dedicated to the manufacture of sterile injectables, Virbac continues to invest in quality and to strengthen its production capacities with Argo Navis, VB8’s alter ego in Mexico.

2017

petfood.png

2016年,维克为犬、猫推出了一系列宠物营养食品。其成分特别适合食肉动物的饮食需求。

After the physiological range in 2016, Virbac launches a range of dietetic petfood for dogs and cats. Their composition is particularly suited to the dietary needs of carnivores.

2017

voile.png

在掌管圣米歇尔-维克的时候,约翰-皮埃尔·迪克赢得了他的第四届雅克·瓦布里比赛(这是 Coffee Race 历史上的第一次)。这一胜利标志着这位帆船手生命中的一个转折点,也是他17年环游世界冒险生涯中最完美的结束。

At the helm of St. Michel-Virbac, Jean-Pierre Dick wins his fourth Jacques Vabre Race (a first in the history of the Coffee Race). This victory marks a turning point in the life of the sailor and the most fitting closure to his 17 years of adventures around the world, flying Virbac’s colors.

2017

SH.png

现年47岁的塞巴斯蒂安·休伦(Sebastien Huron)是兽医学博士、全球业务运营主管,自2012年起担任维克董事长,他接替了埃里克·马里(Eric Maree)。

Sébastien Huron, 47 years old, doctor of veterinary medicine, head of Global Business Operations, and member of the executive board since 2012, succeeds Éric Marée as chairman of Virbac.

Legal notice
All medicines or products mentioned in this document can be not authorized or not marketed in all the countries including France. The product names stated in this document are subject to protection in particular in respect of trademarks. Virbac and/or its subsidiaries are the owners or have exclusive use of them.